BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 7601426)

  • 1. Inhibition of gallbladder emptying decreases cholesterol saturation in bile in the Richardson ground squirrel.
    Pauletzki JG; Xu QW; Shaffer EA
    Hepatology; 1995 Jul; 22(1):325-31. PubMed ID: 7601426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the prokinetic agent, erythromycin, in the Richardson ground squirrel model of cholesterol gallstone disease.
    Xu QW; Scott RB; Tan DT; Shaffer EA
    Hepatology; 1998 Sep; 28(3):613-9. PubMed ID: 9731548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slow intestinal transit: a motor disorder contributing to cholesterol gallstone formation in the ground squirrel.
    Xu QW; Scott RB; Tan DT; Shaffer EA
    Hepatology; 1996 Jun; 23(6):1664-72. PubMed ID: 8675191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tegaserod on bile composition and hepatic secretion in Richardson ground squirrels on an enriched cholesterol diet.
    Mathison R; Shaffer E; Pfannkuche HJ; Earnest D
    Lipids Health Dis; 2006 Jun; 5():15. PubMed ID: 16792807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained gallbladder stasis promotes cholesterol gallstone formation in the ground squirrel.
    Xu QW; Mantle M; Pauletzki JG; Shaffer EA
    Hepatology; 1997 Oct; 26(4):831-6. PubMed ID: 9328300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisapride improves gallbladder contractility and bile lipid composition in an animal model of gallstone disease.
    Xu QW; Shaffer EA
    Gastroenterology; 1993 Oct; 105(4):1184-91. PubMed ID: 8405865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective gallbladder contractility in the ground squirrel and prairie dog during the early stages of cholesterol gallstone formation.
    Fridhandler TM; Davison JS; Shaffer EA
    Gastroenterology; 1983 Oct; 85(4):830-6. PubMed ID: 6309603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.
    Wang HH; Portincasa P; Wang DQ
    Eur J Clin Invest; 2016 Feb; 46(2):158-69. PubMed ID: 26683129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triglycerides and gallstone formation.
    Smelt AH
    Clin Chim Acta; 2010 Nov; 411(21-22):1625-31. PubMed ID: 20699090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of cholesterol in bile on cholecystokinin receptor in the gallbladder].
    Fu H; Wu W; Zou S; Huang M; Huang C; Xu Y
    Zhonghua Wai Ke Za Zhi; 2002 Oct; 40(10):786-8. PubMed ID: 12487887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin prophylaxis of parenteral nutrition-induced gallbladder disease.
    Doty JE; Pitt HA; Porter-Fink V; Denbesten L
    Ann Surg; 1985 Jan; 201(1):76-80. PubMed ID: 3917658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of gallbladder cholecystokinin: a receptor in prairie dogs fed a high-cholesterol diet and its dissociation with decreased contractility in response to cholecystokinin.
    Kano M; Shoda J; Satoh S; Kobayashi M; Matsuzaki Y; Abei M; Tanaka N
    J Lab Clin Med; 2002 May; 139(5):285-94. PubMed ID: 12032489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of decreased gallbladder stimulation on enterohepatic cycling and kinetics of bile acids.
    Hepner GW
    Gastroenterology; 1975 Jun; 68(6):1574-81. PubMed ID: 1132637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.
    Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Coker LD; Turnbull TA; Morita ET
    J Clin Invest; 1989 Oct; 84(4):1220-5. PubMed ID: 2794058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of diet on hepatic bile formation and bile acid metabolism in squirrel monkeys with and without cholesterol gallstones.
    Osuga T; Portman OW; Tanaka N; Alexander M; Ochsner AJ
    J Lab Clin Med; 1976 Oct; 88(4):649-61. PubMed ID: 823283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired gallbladder emptying before gallstone formation in the prairie dog.
    Doty JE; Pitt HA; Kuchenbecker SL; DenBesten L
    Gastroenterology; 1983 Jul; 85(1):168-74. PubMed ID: 6303888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of hypolipidemic treatment on the composition of bile and the risk or cholesterol gallstone disease].
    Zák A; Zeman M; Hrubant K; Vecka M; Tvrzická E
    Cas Lek Cesk; 2007; 146(1):24-34. PubMed ID: 17310581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential site of disordered gallbladder contractility during the early stage of cholesterol gallstone formation.
    Mansour A; Dawoud I; Gad-El-Hak N
    Hepatogastroenterology; 1998; 45(23):1404-9. PubMed ID: 9840074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit.
    Shoda J; He BF; Tanaka N; Matsuzaki Y; Osuga T; Yamamori S; Miyazaki H; Sjövall J
    Hepatology; 1995 May; 21(5):1291-302. PubMed ID: 7737634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biliary lipid secretion, bile acid metabolism, and gallstone formation are not impaired in hepatic lipase-deficient mice.
    Amigo L; Mardones P; Ferrada C; Zanlungo S; Nervi F; Miquel JF; Rigotti A
    Hepatology; 2003 Sep; 38(3):726-34. PubMed ID: 12939599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.